Biden’s last chance to tackle tobacco: Limiting nicotine levels in cigarettes
In its final days of authority, the Biden administration is anticipated to formally suggest a restriction on nicotine in cigarettes.…
Category: Departments Finance
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
In this article, Amgen announced on Tuesday that its experimental weight loss injection showed promising results in a critical mid-stage…
A norovirus vaccine could be on the horizon as cases rise
In this article, Norovirus is spreading rapidly across the U.S. this winter, and Moderna is working on developing a vaccine…
Merck tops earnings estimates on strong demand for Keytruda even as HPV vaccine sales fall
In this article, Merck reported third-quarter revenue and adjusted earnings that exceeded expectations due to strong sales of its top-selling…
23andMe appoints three new board members following abrupt resignations
In this article, 23andMe announced the appointment of three new independent directors to its board on Tuesday, following the sudden…
Former Pfizer CEO, finance chief step back from Starboard’s activist campaign
Former Pfizer CEO Ian Read and ex-CFO Frank D’Amelio announced on Wednesday evening that they would withdraw from Starboard Value’s…
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says
In this article, Medicare drug plans can now cover Eli Lilly’s blockbuster obesity drug Zepbound for obstructive sleep apnea, as…
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
In this article, Novo Nordisk’s diabetes drug Ozempic is highlighted for its potential to reduce the risk of developing Alzheimer’s…
Healthy Returns: Novo Nordisk’s Ozempic faces scrutiny over potential link to rare eye condition
In this article A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care…